NCT06363045

Brief Summary

The primary objective of this clinical study is to prove that tonometry values for NIDEK TONOREF III are comparable to the predicate device and to prove that the pachymeter function of NIDEK TONOREF III is equivalent to the predicate device. The secondary objective is to demonstrate that the test device is as safe as the predicate devices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
183

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 24, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

April 12, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

June 27, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2024

Completed
Last Updated

March 7, 2025

Status Verified

March 1, 2025

Enrollment Period

6 months

First QC Date

March 24, 2024

Last Update Submit

March 6, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Equivalent to legally-marketed devices

    Agreement of intraocular pressure (mmHg) measurement for TONOREFIII and PAT

    One or two study visits per subject. One visit is less than two hours.

  • Equivalent to the pachymeter function

    Agreement of central corneal thickness (µm) measurement for TONOREF III and CEM-530

    One or two study visits per subject. One visit is less than two hours.

Secondary Outcomes (1)

  • The numbers of adverse events

    One or two study visits per subject. One visit is less than two hours.

Study Arms (1)

Adults 18 years old or older

EXPERIMENTAL

NIDEK TONOREFIII

Device: NIDEK TONOREF IIIDevice: Haag-Streit, PERKINS HAND-HELD APPLANATION TONOMETERDevice: NIDEK CEM-530

Interventions

The auto ref/kerato/tono/pachymeter TONOREF III is a medical device which measures objective refractive errors, corneal curvature radius, intraocular pressure and corneal thickness of the patient's eye.

Adults 18 years old or older

Haag-Streit Goldmann Manual Tonometer measures intraocular pressure to aid in the screening and diagnosis of glaucoma

Adults 18 years old or older

Nidek CEM-530 is a non-contact ophthalmic microscope, optical pachymeter, and camera used for examination of the corneal endothelium and for measurement of the thickness of the cornea.

Adults 18 years old or older

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Subjects with only one functional eye;
  • Those with one eye having poor or eccentric fixation;
  • Those with corneal scarring or who have had corneal surgery including corneal laser surgery;
  • Microphthalmos;
  • Buphthalmos;
  • Contact lens wearers;
  • Dry eyes;
  • Lid squeezers - blepharospasm;
  • Nystagmus;
  • Keratoconus;
  • Any other corneal or conjunctival pathology or infection.
  • central corneal thickness greater than 0,600 mm or less than 0,500 mm (2 standard deviations about the human mean)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aston University

Birmingham, Birmingham, B4 7ET, UK, United Kingdom

Location

Study Officials

  • Tadakazu Ichimura

    Nidek Co. LTD.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2024

First Posted

April 12, 2024

Study Start

June 27, 2024

Primary Completion

December 13, 2024

Study Completion

December 13, 2024

Last Updated

March 7, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations